This set of Standards is formulated in accordance with the regulations of Article 10 of the Charge And Fees Act.
This set of Standards applies to the biological products manufactured and commissioned for production by the Centers for Disease Control, Ministry of Health and Welfare.
The biological products mentioned in this set of Standards are Antivenins.
Items and fees charged for the manufactured and supplied biological products are as shown in the Attachment.
This set of Standards shall enter into force on January 1, 2017.
The Attachment to Article 4 of these standards, amended on May 10, 2019, shall enter into force on July 1, 2019.